Skip to content

ENSYSCE BIOSCIENCES, INC.: 10-Q filed 2023-08-11

What ENSYSCE BIOSCIENCES, INC. reported in its quarterly report filed 2023-08-11 (fiscal Q2 2023): 33 published measures, 94 facts as tagged in accession 0001493152-23-027659.

This filing

Form
10-Q (quarterly report)
Filed
2023-08-11
Fiscal period
fiscal Q2 2023
Accession
0001493152-23-027659 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ENSYSCE BIOSCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-06-306,357,623USD
At 2022-12-315,885,052USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-06-302,564,816USD
At 2022-12-319,914,704USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-06-304,119,016USD
At 2022-12-31-3,714,444USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2023-06-303,829,482USD
At 2022-12-313,147,702USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-6,715,461USD181
2022-01-01 to 2022-06-30-7,877,508USD181

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2023-04-01 to 2023-06-30490,472USD91
2023-01-01 to 2023-06-301,280,107USD181
2022-04-01 to 2022-06-30207,471USD91
2022-01-01 to 2022-06-30810,569USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-01-01 to 2023-06-307,397,241USD181
2022-01-01 to 2022-06-30-657,082USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-06-304,500USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-06-30-115,363,208USD
At 2022-12-31-110,931,063USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-04-01 to 2023-06-302,274,113shares91
2023-01-01 to 2023-06-301,667,527shares181
2022-04-01 to 2022-06-30141,615shares91
2022-01-01 to 2022-06-30127,732shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2023-04-01 to 2023-06-302,274,113shares91
2023-01-01 to 2023-06-301,667,527shares181
2022-04-01 to 2022-06-30141,615shares91
2022-01-01 to 2022-06-30127,732shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-0.98USD/shares91
2023-01-01 to 2023-06-30-2.66USD/shares181
2022-04-01 to 2022-06-30-56.49USD/shares91
2022-01-01 to 2022-06-30-75.67USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-0.98USD/shares91
2023-01-01 to 2023-06-30-2.66USD/shares181
2022-04-01 to 2022-06-30-56.49USD/shares91
2022-01-01 to 2022-06-30-75.67USD/shares181

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-01-01 to 2023-06-30194,550USD181
2022-01-01 to 2022-06-30698,013USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-2,293,954USD91
2023-01-01 to 2023-06-30-4,855,188USD181
2022-04-01 to 2022-06-30-7,055,183USD91
2022-01-01 to 2022-06-30-11,857,986USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-06-305,855,073USD
At 2022-12-315,299,169USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-01-01 to 2023-06-301,497USD181
2022-04-01 to 2022-06-3037,781USD91
2022-01-01 to 2022-06-3052,802USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-06-302,517,120USD
At 2022-12-319,464,210USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2023-06-301,274,629USD
At 2022-12-312,943,791USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-04-01 to 2023-06-302,784,426USD91
2023-01-01 to 2023-06-306,135,295USD181
2022-04-01 to 2022-06-307,262,654USD91
2022-01-01 to 2022-06-3012,668,555USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2023-04-01 to 2023-06-301,643,726USD91
2023-01-01 to 2023-06-303,439,742USD181
2022-04-01 to 2022-06-305,311,298USD91
2022-01-01 to 2022-06-308,451,394USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-06-302,669,792shares
At 2022-12-31534,490shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-06-30119,481,957USD
At 2022-12-31107,216,566USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2023-06-303,792,807USD
At 2023-03-31-152,424USD
At 2022-12-31-4,029,652USD
At 2022-06-30-797,578USD
At 2022-03-311,111,273USD
At 2021-12-31-8,158,058USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2023-06-30502,550USD
At 2022-12-31585,883USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-2,239,302USD91
2023-01-01 to 2023-06-30-4,431,108USD181
2022-04-01 to 2022-06-30-7,923,120USD91
2022-01-01 to 2022-06-30-8,874,044USD181

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-2,235,971USD91
2023-01-01 to 2023-06-30-4,432,145USD181
2022-04-01 to 2022-06-30-7,999,290USD91
2022-01-01 to 2022-06-30-9,665,976USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2023-04-01 to 2023-06-301,140,700USD91
2023-01-01 to 2023-06-302,695,553USD181
2022-04-01 to 2022-06-301,951,356USD91
2022-01-01 to 2022-06-304,217,161USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2023-04-01 to 2023-06-3011,030USD91
2023-01-01 to 2023-06-3016,448USD181
2022-04-01 to 2022-06-302,850USD91
2022-01-01 to 2022-06-3010,816USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2023-04-01 to 2023-06-3054,652USD91
2023-01-01 to 2023-06-30424,080USD181
2022-04-01 to 2022-06-30-867,937USD91
2022-01-01 to 2022-06-302,983,942USD181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2022-01-01 to 2022-06-301,600USD181

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2023-01-01 to 2023-06-3010,926USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-1,669,162USD181
2022-01-01 to 2022-06-302,746,933USD181

Inspect the source

Entity
ENSYSCE BIOSCIENCES, INC. / CIK 0001716947
Captured
2026-09-21T17:24:39.335Z
SEC response SHA-256
28573a09f81da1511239531464c03b2552a3554a684a233653f365b194b6ca0b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001716947.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))